SM
TMO icon

Stephen Mandel’s Thermo Fisher Scientific TMO Stock Holding History

Stephen Mandel’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-587,696
Closed -$324M – 32
2022
Q4 		$324M Sell
587,696
-297,630
-34% -$158M 3.09% 14
2022
Q3 		$449M Sell
885,326
-46,966
-5% -$26.3M 4.23% 10
2022
Q2 		$506M Buy
932,292
+411,583
+79% +$227M 4.77% 8
2022
Q1 		$308M Buy
+520,709
New +$299M 1.83% 22
2013
Q3 		– Sell
-2,766,476
Closed -$234M – 64
2013
Q2 		$234M Buy
+2,766,476
New +$230M 1.14% 38

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Stephen Mandel's TMO Position: Q1 2023 in Review

Stephen Mandel sold out of Thermo Fisher Scientific (TMO) in Q1 2023, closing a stake of 587,696 shares — an estimated $324M sold.

Stephen Mandel first reported a position in TMO in Q2 2013 and held it in 5 quarters. The position peaked at $506M in Q2 2022. 2,387 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

  • Stephen Mandel reported no remaining Thermo Fisher Scientific position as of Q1 2023 after selling out during the quarter.
  • Stephen Mandel sold 587,696 Thermo Fisher Scientific shares in Q1 2023, an estimated $324M.
  • Stephen Mandel first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 5 quarters.
  • Stephen Mandel's Thermo Fisher Scientific position peaked at $506M in Q2 2022.
  • 2,387 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on Lone Pine Capital's 13F filing for Q1 2023, filed 15 May 2023.